Pro/con clinical debate: It is acceptable to stop large multicentre randomized controlled trials at interim analysis for futility

37Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A few recent, large, well-publicized trials in critical care medicine have been stopped for futility. In the critical care setting, stopping for futility means that independent review committees have elected to stop the trial early - based on predetermined rules - since the likelihood of finding a treatment effect is low. For bedside clinicians the idea of futility in a clinical trial can be confusing. In the present article, two experts in the conduct of clinical trials debate the role of futility-stopping rules. © 2004 BioMed Central Ltd.

Cite

CITATION STYLE

APA

Schoenfeld, D. A., & Meade, M. O. (2005, February). Pro/con clinical debate: It is acceptable to stop large multicentre randomized controlled trials at interim analysis for futility. Critical Care. https://doi.org/10.1186/cc3013

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free